v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 19,461 $ 14,101
General and administrative 4,151 2,459
Total operating expenses 23,612 16,560
Loss from operations (23,612) (16,560)
Other income (expense), net:    
Interest income 1,219 473
Other (expense) income, net (282) 591
Total other income, net 937 1,064
Loss before income tax expense (22,675) (15,496)
Income tax (expense) benefit (12) 190
Net loss $ (22,687) $ (15,306)
Earnings Per Share, Basic $ (23.98) $ (16.18)
Earnings Per Share, Diluted $ (23.98) $ (16.18)
Weighted Average Number of Shares Outstanding, Basic 946,000 946,000
Weighted Average Number of Shares Outstanding, Diluted 946,000 946,000
Other comprehensive (loss) income:    
Net Income (Loss) $ (22,687) $ (15,306)
Net unrealized gain (loss) on available-for-sale debt securities (614) 974
Total comprehensive loss $ (23,301) $ (14,332)